These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Anandamide down-regulates placental transporter expression through CB2 receptor-mediated inhibition of cAMP synthesis. Szilagyi JT, Composto-Wahler GM, Joseph LB, Wang B, Rosen T, Laskin JD, Aleksunes LM. Pharmacol Res; 2019 Mar 01; 141():331-342. PubMed ID: 30610963 [Abstract] [Full Text] [Related]
3. The breast cancer resistance protein (Bcrp1/Abcg2) limits fetal distribution of glyburide in the pregnant mouse: an Obstetric-Fetal Pharmacology Research Unit Network and University of Washington Specialized Center of Research Study. Zhou L, Naraharisetti SB, Wang H, Unadkat JD, Hebert MF, Mao Q. Mol Pharmacol; 2008 Mar 01; 73(3):949-59. PubMed ID: 18079276 [Abstract] [Full Text] [Related]
4. Localization of the placental BCRP/ABCG2 transporter to lipid rafts: Role for cholesterol in mediating efflux activity. Szilagyi JT, Vetrano AM, Laskin JD, Aleksunes LM. Placenta; 2017 Jul 01; 55():29-36. PubMed ID: 28623970 [Abstract] [Full Text] [Related]
5. P-gp/ABCB1 exerts differential impacts on brain and fetal exposure to norbuprenorphine. Liao MZ, Gao C, Shireman LM, Phillips B, Risler LJ, Neradugomma NK, Choudhari P, Prasad B, Shen DD, Mao Q. Pharmacol Res; 2017 May 01; 119():61-71. PubMed ID: 28111265 [Abstract] [Full Text] [Related]
6. Interactions between Maraviroc and the ABCB1, ABCG2, and ABCC2 Transporters: An Important Role in Transplacental Pharmacokinetics. Tupova L, Ceckova M, Ambrus C, Sorf A, Ptackova Z, Gaborik Z, Staud F. Drug Metab Dispos; 2019 Sep 01; 47(9):954-960. PubMed ID: 31266750 [Abstract] [Full Text] [Related]
7. In Vitro Screening of Environmental Chemicals Identifies Zearalenone as a Novel Substrate of the Placental BCRP/ABCG2 Transporter. Xiao J, Wang Q, Bircsak KM, Wen X, Aleksunes LM. Toxicol Res (Camb); 2015 May 01; 4(3):695-706. PubMed ID: 26052432 [Abstract] [Full Text] [Related]
9. Glucocorticoids modulate multidrug resistance transporters in the first trimester human placenta. Lye P, Bloise E, Nadeem L, Gibb W, Lye SJ, Matthews SG. J Cell Mol Med; 2018 Jul 01; 22(7):3652-3660. PubMed ID: 29691980 [Abstract] [Full Text] [Related]
10. Placental transfer of the estrogenic mycotoxin zearalenone in rats. Bernhoft A, Behrens GH, Ingebrigtsen K, Langseth W, Berndt S, Haugen TB, Grotmol T. Reprod Toxicol; 2001 Jul 01; 15(5):545-50. PubMed ID: 11780962 [Abstract] [Full Text] [Related]
11. Modulation of Placental Breast Cancer Resistance Protein by HDAC1 in Mice: Implications for Optimization of Pharmacotherapy During Pregnancy. Wang C, Ma D, Hua Y, Duan H. Reprod Sci; 2021 Dec 01; 28(12):3540-3546. PubMed ID: 34668144 [Abstract] [Full Text] [Related]
12. An update on expression and function of P-gp/ABCB1 and BCRP/ABCG2 in the placenta and fetus. Han LW, Gao C, Mao Q. Expert Opin Drug Metab Toxicol; 2018 Aug 01; 14(8):817-829. PubMed ID: 30010462 [Abstract] [Full Text] [Related]
13. Maternal and Fetal Exposure to (-)-Δ9-tetrahydrocannabinol and Its Major Metabolites in Pregnant Mice Is Differentially Impacted by P-glycoprotein and Breast Cancer Resistance Protein. Chen X, Unadkat JD, Mao Q. Drug Metab Dispos; 2023 Mar 01; 51(3):269-275. PubMed ID: 36446608 [Abstract] [Full Text] [Related]
14. Breast Cancer Resistance Protein Limits Fetal Transfer of Tadalafil in Mice. Nishimura T, Ishii M, Tanaka H, Noguchi S, Ikeda T, Tomi M. J Pharm Sci; 2024 Feb 01; 113(2):486-492. PubMed ID: 37981232 [Abstract] [Full Text] [Related]
15. Down-regulation of the placental BCRP/ABCG2 transporter in response to hypoxia signaling. Francois LN, Gorczyca L, Du J, Bircsak KM, Yen E, Wen X, Tu MJ, Yu AM, Illsley NP, Zamudio S, Aleksunes LM. Placenta; 2017 Mar 01; 51():57-63. PubMed ID: 28292469 [Abstract] [Full Text] [Related]
16. Interindividual Regulation of the Breast Cancer Resistance Protein/ABCG2 Transporter in Term Human Placentas. Bircsak KM, Moscovitz JE, Wen X, Archer F, Yuen PYS, Mohammed M, Memon N, Weinberger BI, Saba LM, Vetrano AM, Aleksunes LM. Drug Metab Dispos; 2018 May 01; 46(5):619-627. PubMed ID: 29386232 [Abstract] [Full Text] [Related]
17. Protective role of the placental efflux transporter BCRP/ABCG2 in the relationship between prenatal cadmium exposure, placenta weight, and size at birth. Barrett ES, Rivera-Núñez Z, Getz K, Ohman-Strickland P, Zhang R, Kozlosky D, Doherty CL, Buckley BT, Brunner J, Miller RK, O'Connor TG, Aleksunes LM. Environ Res; 2023 May 15; 225():115597. PubMed ID: 36863650 [Abstract] [Full Text] [Related]
18. Estimation of Fetal-to-Maternal Unbound Steady-State Plasma Concentration Ratio of P-Glycoprotein and/or Breast Cancer Resistance Protein Substrate Drugs Using a Maternal-Fetal Physiologically Based Pharmacokinetic Model. Peng J, Ladumor MK, Unadkat JD. Drug Metab Dispos; 2022 May 15; 50(5):613-623. PubMed ID: 35149540 [Abstract] [Full Text] [Related]
19. Genetic and Dietary Regulation of Glyburide Efflux by the Human Placental Breast Cancer Resistance Protein Transporter. Bircsak KM, Gupta V, Yuen PY, Gorczyca L, Weinberger BI, Vetrano AM, Aleksunes LM. J Pharmacol Exp Ther; 2016 Apr 15; 357(1):103-13. PubMed ID: 26850786 [Abstract] [Full Text] [Related]
20. Prenatal endotoxemia and placental drug transport in the mouse: placental size-specific effects. Bloise E, Bhuiyan M, Audette MC, Petropoulos S, Javam M, Gibb W, Matthews SG. PLoS One; 2013 Apr 15; 8(6):e65728. PubMed ID: 23762418 [Abstract] [Full Text] [Related] Page: [Next] [New Search]